MedPath

PIRMELLA 7/7/7

Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets

Approved
Approval ID

1d34bba2-6223-46cb-a83f-ebb9145626be

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2022

Manufacturers
FDA

Lupin Pharmaceuticals, Inc.

DUNS: 089153071

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NORETHINDRONE AND ETHINYL ESTRADIOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68180-892
Application NumberANDA201510
Product Classification
M
Marketing Category
C73584
G
Generic Name
NORETHINDRONE AND ETHINYL ESTRADIOL
Product Specifications
Effective DateDecember 20, 2022
FDA Product Classification

NORETHINDRONE AND ETHINYL ESTRADIOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68180-893
Application NumberANDA201512
Product Classification
M
Marketing Category
C73584
G
Generic Name
NORETHINDRONE AND ETHINYL ESTRADIOL
Product Specifications
Effective DateDecember 20, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PIRMELLA 7/7/7 - FDA Drug Approval Details